Phraction Management’s Boston Scientific BSX Stock Holding History

Phraction Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.56M	Sell	36,558 -50	-0.1%	-$2.71K	0.26%	38
2026 Q1	$2.3M	Buy	+36,608	New	+$2.93M	0.48%	34
2022 Q4	–	Sell	-12,205	Closed	-$473K	–	49
2022 Q3	$473K	Sell	12,205 -20,000	-62%	-$802K	0.36%	39
2022 Q2	$1.2M	Buy	32,205 +525	+2%	+$21.4K	0.79%	36
2022 Q1	$1.4M	Buy	31,680 +940	+3%	+$40.7K	0.81%	39
2021 Q4	$1.31M	Buy	+30,740	New	+$1.29M	0.79%	35

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

GIA

Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

Phraction Management's BSX Position: Q2 2026 in Review

Phraction Management reduced its Boston Scientific (BSX) stake by 0.14% in Q2 2026, selling an estimated $2.71K and leaving 36,558 shares worth $1.56M. The position accounts for 0.26% of the portfolio, ranked #38.

Phraction Management first reported a position in BSX in Q4 2021 and has held it in 6 quarters since. The position peaked at $2.3M in Q1 2026. 227 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Phraction Management held 36,558 shares of Boston Scientific worth $1.56M as of Q2 2026.
Phraction Management sold 50 Boston Scientific shares in Q2 2026, an estimated $2.71K.
Boston Scientific made up 0.26% of Phraction Management's portfolio in Q2 2026, its #38 holding.
Phraction Management first reported a position in Boston Scientific in Q4 2021 and has held it in 6 quarters since.
Phraction Management's Boston Scientific position peaked at $2.3M in Q1 2026.
227 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Phraction Management's 13F filing for Q2 2026, filed 20 Jul 2026.